SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about company updates

23 Mar 2018 Evaluate

Sequent Scientific has informed that the Hon’ble National Company Law Tribunal, Mumbai Bench vide its Order dated March 9, 2018 issued on March 22, 2018 has approved the Composite Scheme involving demerger of Commodity API business of Strides and Human API Business of SeQuent into Solara under the provisions of Sections 230 - 232 and other applicable provisions of the Companies Act, 2013. The Appointed Date for the Demerger is October 1, 2017. The Company shall soon notify the Effective Date of De-merger and the Record Date for determining the entitlement of shareholders to whom Solara will allot shares consequent to the demerger.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×